Marinus Pharmaceuticals Inc

NASDAQ:MRNS   1:00:00 PM EDT
4.57
+0.06 (+1.33%)
4:33:24 PM EDT: $4.75 +0.18 (+3.94%)
Products, Strategic Combinations

Marinus Pharmaceuticals Announces Collaboration With Tenacia Biotechnology For Ganaxolone Development And Commercialization In China

Published: 11/17/2022 12:47 GMT
Marinus Pharmaceuticals Inc (MRNS) - Marinus Pharmaceuticals Announces Collaboration With Tenacia Biotechnology for Ganaxolone Development and Commercialization in China.
Marinus - to Receive Upfront Fee of $10 Million and Eligible to Receive Up to $256 Million in Development, Regulatory and Commercialization Milestone Payments.
Marinus Pharmaceuticals Inc - to Receive Tiered Low Double-digit Royalties on Net Sales in China.
Marinus - Tenacia to Get Exclusive Rights to Develop & Commercialize Some Formulations of Ganaxolone in Mainland China, Hong Kong, Macau & Taiwan.